Who
Hersh Kozlov
Director
Company insider
Files Form 4 as: Director, The Bancorp; Director, vTv Therapeutics; Director, Resource America.
In numbers
- Trades disclosed
- 57
- Buys
- 24
- Sells
- 2
- Bought
- $835K
- Sold
- $106K
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 2 Feb 2007
- Last trade
- 27 May 2026
- Last filed
- 28 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 May 2026filed 28 May 2026 | TBBK The BancorpRegional banks | SEC FORM 4 Code A | —3,600 | filing |
| 27 May 2026filed 28 May 2026 | TBBK The BancorpRegional banks | SEC FORM 4 Code A | —3,600 | filing |
| 28 May 2025filed 30 May 2025 | TBBK The BancorpRegional banks | SEC FORM 4 Code A | —3,861 | filing |
| 30 May 2024filed 31 May 2024 | TBBK The BancorpRegional banks | SEC FORM 4 Code A | —5,105 | filing |
| 7 May 2024filed 7 May 2024 | TBBK The BancorpRegional banks | SEC FORM 4 Bought | $33K1,000 at $32.53 | filing |
| 19 Jun 2023filed 21 Jun 2023 | VTVT vTv Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 25 May 2023filed 26 May 2023 | TBBK The BancorpRegional banks | SEC FORM 4 Code A | —2,782 | filing |
| 1 Jul 2022filed 6 Jul 2022 | VTVT vTv Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —105,128 at $0.00 | filing |
| 25 May 2022filed 26 May 2022 | TBBK The BancorpRegional banks | SEC FORM 4 Code A | —4,598 | filing |
| 3 May 2021filed 5 May 2021 | VTVT vTv Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 26 Feb 2021filed 2 Mar 2021 | VTVT vTv TherapeuticsBiotechnology | SEC FORM 4 Bought | $27K10,000 at $2.74 | filing |
| 9 Feb 2021filed 19 Mar 2021 | TBBK The BancorpRegional banks | SEC FORM 4 Code A | —4,784 | filing |
| 11 Jun 2020filed 15 Jun 2020 | VTVT vTv Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $70K26,250 at $2.65 | filing |
| 20 May 2020filed 21 May 2020 | TBBK The BancorpRegional banks | SEC FORM 4 Code A | —13,100 | filing |
| 15 May 2020filed 18 May 2020 | VTVT vTv TherapeuticsBiotechnology | SEC FORM 4 Bought | $30K10,000 at $3.00 | filing |
| 9 Feb 2020filed 9 Feb 2021 | TBBK The BancorpRegional banks | SEC FORM 4 Code A | —4,784 | filing |
| 13 Sep 2019filed 17 Sep 2019 | VTVT vTv TherapeuticsBiotechnology | SEC FORM 4 Bought | $8,2505,000 at $1.65 | filing |
| 11 Feb 2019filed 11 Feb 2019 | TBBK The BancorpRegional banks | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 16 May 2018filed 17 May 2018 | TBBK The BancorpRegional banks | SEC FORM 4 Code A | —7,500 | filing |
| 1 Mar 2018filed 1 Mar 2018 | TBBK The BancorpRegional banks | SEC FORM 4 Sold | $53K5,000 at $10.58 | filing |
News
FinancialContent - Washington Trust Bancorp (WASH) Stock Trades Up, Here Is WhyTBBK · financialcontent.com · 20 Oct 2026FinancialContent - Washington Trust Bancorp (NASDAQ:WASH) Posts Better-Than-Expected Sales In Q3 2026TBBK · financialcontent.com · 19 Oct 2026Washington Trust Bancorp (NASDAQ:WASH) Announces Earnings ResultsTBBK · themarketsdaily.com · 19 Oct 2026vTv Therapeutics Inc. (NASDAQ:VTVT) Stock Has Average Price Target of $55.83VTVT · dailypolitical.com · 14 Oct 2026Critical Analysis: vTv Therapeutics (NASDAQ:VTVT) and Jazz Pharmaceuticals (NASDAQ:JAZZ)VTVT · tickerreport.com · 12 Oct 2026
0 headlines in the last 90 days name Hersh Kozlov; 5 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.